Press release -
Chr. Hansen has obtained New Quality Certification in the US
As a result of a recent audit by BVQI (Bureau Veritas Quality International), Chr. Hansen has been awarded the FAMI-QS certificate – the state-of-the-art quality certification for feed additives.
The Feed Additive and premixtures Code of Practice, FAMI-QS, is a code that fully integrates ISO 9001 standards, GMP (Good Manufacturing Practices) and HACCP (Hazard Analysis and Critical Control Points) requirements. The certifiable system provides a single reference for ensuring the quality and safety of feed additives on the US market to the great benefit of feed manufacturers and their customers.
As a result of its recent audit, BVQI has certified that Chr. Hansen has implemented and maintains a quality management system in compliance with the FAMI-QS Code of Practice for feed additive and premixture operators for its probiotic feed additive BioPlus® 2B and silage inoculants. The certification falls into the following categories and functional groups - technological additives (silage additives) and zootechnical additives (microorganisms).
Hygiene and safety for the whole feed chain
“The FAMI-QS system provides a single reference for ensuring the quality of our products to the greatest benefit of our customers. FAMI-QS is about hygiene and safety for the whole feed chain. We are very happy to be certified on this by the most widely recognized independent certification body, BVQI,” says Bill Braman, Vice President Marketing and Sales, Animal Health & Nutrition, Chr. Hansen North America.
“Furthermore, it is a part of Chr. Hansen’s Global strategy always to fulfill our customers’ expectations and in this respect to ensure compliance with the highest level of safety management systems, Bill Braman adds.”
Chr. Hansen was the first company to obtain the FAMI-QS certificate for the EU markets.
Topics
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.
